Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD

BACKGROUND: Budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) is a triple fixed-dose combination for COPD. The long-term safety of triple therapy for COPD has not been investigated in Japanese patients. In this 28-week extension study (NCT03262012), we investigated the lon...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichinose, Masakazu, Fukushima, Yasushi, Inoue, Yoshikazu, Hataji, Osamu, Ferguson, Gary T, Rabe, Klaus F, Hayashi, Nobuya, Okada, Hiroshi, Takikawa, Mami, Bourne, Eric, Ballal, Shaila, DeAngelis, Kiernan, Aurivillius, Magnus, Reisner, Colin, Dorinsky, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934178/
https://www.ncbi.nlm.nih.gov/pubmed/31920296
http://dx.doi.org/10.2147/COPD.S220861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934178/
https://www.ncbi.nlm.nih.gov/pubmed/31920296
http://dx.doi.org/10.2147/COPD.S220861

Ejemplares similares